Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT) such as eculizumab (Soliris®) and ravulizumab (Ultomiris®).
Epistemonikos ID: a881ac4c227c6881586556f50628a6554b64771c
First added on: May 06, 2024